Baker Avenue Asset Management, LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1432529 SAN FRANCISCO, CA

Position in REGN

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$580,515

-$239,256 QoQ

Shares Held

931

-12.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#770

of 1,322 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 89% Shared 0% None 11%

Healthcare · as of Jun 30, 2026

Baker Avenue Asset Management, LP holds $4,381,815 across 10 Biotechnology names. REGN ranks #4 (13.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VCEL	Vericel Corp	26,219	$1,166,483
2	PCVX	Vaxcyte, Inc.	13,279	$771,908
3	JAZZ	Jazz Pharmaceuticals plc	2,447	$589,653
4	REGN	Regeneron Pharmaceuticals, Inc. This page	931	$580,515
5	RPRX	Royalty Pharma plc	6,991	$391,985
6	VRTX	Vertex Pharmaceuticals Inc / Ma	653	$324,364
7	INCY	Incyte Corp	2,148	$243,497
8	EXEL	Exelixis, Inc.	3,885	$211,382

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$580,515	931	-12.3%	Shares	Sole	2026-07-28
2026-03-31	$819,771	1,061	+177.0%	Shares	Sole	2026-05-12
2025-12-31	$295,626	383	-54.8%	Shares	Sole	2026-02-10
2025-09-30	$476,804	848	+37.0%	Shares	Sole	2025-10-31
2025-06-30	$324,975	619	-4.3%	Shares	Sole	2025-08-13
2025-03-31	$410,346	647	-0.5%	Shares	Sole	2025-05-08
2024-12-31	$463,014	650	-3.4%	Shares	Sole	2025-02-14
2024-09-30	$707,484	673	+1429.5%	Shares	Sole	2024-11-04
2023-09-30	$36,210	44	+2.3%	Shares	Sole	2023-11-15
2023-06-30	$30,897	43	-94.5%	Shares	Sole	2023-08-14
2023-03-31	$645,832	786	+15.6%	Shares	Sole	2023-05-16
2022-12-31	$490,613	680	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.